
Ensign Peak Advisors’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $70.2M | Sell |
180,383
-13,325
| -7% | -$5.18M | 0.12% | 158 |
|
2025
Q1 | $84.3M | Buy |
193,708
+62,619
| +48% | +$27.2M | 0.16% | 132 |
|
2024
Q4 | $48.4M | Sell |
131,089
-3,671
| -3% | -$1.35M | 0.09% | 194 |
|
2024
Q3 | $70.1M | Buy |
134,760
+74,645
| +124% | +$38.8M | 0.12% | 144 |
|
2024
Q2 | $32.6M | Buy |
60,115
+2,862
| +5% | +$1.55M | 0.06% | 226 |
|
2024
Q1 | $29.7M | Sell |
57,253
-25,434
| -31% | -$13.2M | 0.05% | 254 |
|
2023
Q4 | $39M | Sell |
82,687
-78,202
| -49% | -$36.9M | 0.08% | 215 |
|
2023
Q3 | $70.1M | Buy |
160,889
+2,799
| +2% | +$1.22M | 0.15% | 130 |
|
2023
Q2 | $70.2M | Sell |
158,090
-19,037
| -11% | -$8.46M | 0.14% | 132 |
|
2023
Q1 | $81.4M | Sell |
177,127
-77,243
| -30% | -$35.5M | 0.18% | 118 |
|
2022
Q4 | $130M | Sell |
254,370
-3,412
| -1% | -$1.75M | 0.29% | 86 |
|
2022
Q3 | $117M | Buy |
257,782
+26,720
| +12% | +$12.1M | 0.29% | 81 |
|
2022
Q2 | $112M | Sell |
231,062
-26,132
| -10% | -$12.6M | 0.27% | 89 |
|
2022
Q1 | $126M | Buy |
257,194
+27,358
| +12% | +$13.4M | 0.26% | 92 |
|
2021
Q4 | $107M | Buy |
229,836
+6,160
| +3% | +$2.86M | 0.2% | 110 |
|
2021
Q3 | $83.4M | Buy |
223,676
+48,039
| +27% | +$17.9M | 0.17% | 126 |
|
2021
Q2 | $67.1M | Buy |
175,637
+5,385
| +3% | +$2.06M | 0.14% | 148 |
|
2021
Q1 | $61.1M | Sell |
170,252
-16,671
| -9% | -$5.98M | 0.13% | 151 |
|
2020
Q4 | $60M | Sell |
186,923
-40,046
| -18% | -$12.9M | 0.14% | 145 |
|
2020
Q3 | $61M | Sell |
226,969
-1,661
| -0.7% | -$446K | 0.15% | 120 |
|
2020
Q2 | $60.1M | Buy |
228,630
+100,159
| +78% | +$26.3M | 0.16% | 118 |
|
2020
Q1 | $29.2M | Buy |
128,471
+35,721
| +39% | +$8.11M | 0.1% | 157 |
|
2019
Q4 | $28M | Buy |
+92,750
| New | +$28M | 0.07% | 234 |
|